Try our Advanced Search for more refined results

February 11, 2022

Pfizer Inc. et al v. Teva Pharmaceuticals USA, Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 14, 2022

    Pfizer Hits Teva With Suit Over Arthritis Drug Patent

    Pfizer has sued Teva Pharmaceuticals in Delaware federal court for allegedly rushing to make a generic version of Pfizer's arthritis drug Xeljanz XR before a patent on the treatment expires.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login